Some of the features of BioRunUp.com include:

- Detailed Reports on Upcoming FDA and Clinical Trial Trades
- Weekly Video Watchlist
- REAL TIME Posting of Trades (Entries and Exits)
- Clinical and Regulatory Catalyst Database with over 400 events and updated daily
- Members Only Live Interactive Webinars
- Live Chat Room
- Video Lessons / Trade Reviews
- SMS Alerts of breaking biotech news
- Access to our trading accounts 
- Watch FOUR Profitable Biotech Traders in Real Time
- A More Detailed FDA Calendar
- Historical FDA Tracker
- Bio-Pharma, FDA, Clinical Trials, and Stock Market News Updates
- Direct Email Communication
- Affiliate Program

The cost for an annual subscription is $697 and includes all the above features. We also offer a monthly plan for $99.95

 CLICK HERE TO JOIN BIORUNUP



Sign up for our free newsletter. 
It’s the best way to stay informed about upcoming catalysts, new website content, and special announcements / offers.

 


Recent Profits of over $1,200,000


Take a look at excerpts from BioRunUp subscriber testimonials:

"My most recent and profitable trade are the EXAS Oct $5 options which I purchased at $.40 off of BioRunUp blog alert. They are currently yielding a 700% return!!!"

"Within 1 month my brand new porfolio was up over 23%!"

"In the first month I made a 13% return, doubling the return of the market as a whole - without leverage. To date, I have never failed to beat the market when applying the methods outlined in the pages of BioRunUp."

"I don’t ever take recommendations from people on the Internet, but this one looked right, felt right and sounded right. Thanks BioRunUp, you made me a fortune."


To read more testimonials, click HERE

 

 

Recent articles

 

$EXEL Exelixis: Cancer Biotech With Multiple Catalysts In 2015

(in: Articles)
 

$NEOT Neothetics: Cosmetic Medicine Specialist Targeting Spot Fat Reduction

(in: Articles)
 

This Week's Watchlist 03/02/15

(in: Articles)
 

$RPTP Raptor: Rare Disease Specialist With Multiple Catalysts In 2015

(in: Articles)
 

$SGYP Synergy Poised For Run-Up Into Phase 3 Results

(in: Articles)
 

$RARE Ultragenyx: Rare Disease Specialist With Multiple Catalysts

(in: Articles)
 

$GEVA Synageva: Rare Disease Drug Developer With PDUFA Catalyst

(in: Articles)
 

2/26/15 Webinar Available for On-Demand Viewing

(in: Articles)
 

$CLDX Celldex: Cancer Biotech With Robust Pipeline And Major 2015 Catalysts

(in: Articles)
 

$SYN Synthetic Biologics: Multiple Clinical Catalysts In 2015

(in: Articles)
 

$GLMD Galmed Bounces Off Lows Ahead Of Clinical Data Catalysts

(in: Articles)
 

BioRunUp Webinar - Thursday 2/26/15 4:30pm est

(in: Articles)
 

2/23/15 Catalyst Summary

(in: Articles)
 

$VNDA Vanda: CNS Specialist With Multiple Catalysts And Marketed Products

(in: Articles)
 

This Week's Watchlist 02/23/15

(in: Articles)
 

$SPPI Spectrum Tanks On Fusilev Court Ruling

(in: Articles)
 

$HRTX Heron Therapeutics: Phase 3 & FDA Catalysts Pending For Sustol

(in: Articles)
 

2/17/15 Catalyst Summary

(in: Articles)
 

$RPRX Repros Files For FDA Approval Of Androxal

(in: Articles)
 

$CLDN Celladon: Gene Therapy Biotech With April Clinical Data Catalyst

(in: Articles)